Tag Archives: Future

M&A professionals see bright future for healthcare deals, despite political uncertainties

Despite considerable trepidation about international politics, most merger and acquisition professionals believe healthcare deal-making will continue apace in the coming year, according to a recent poll. The Merrill Insight survey of more than 200 global M&A professionals found  52 percent of respondents believe that the M&A market is headed in a positive direction in the… Read More »

Medical News Today: Ultrasound: The future of diabetes treatment?

A recent study in mice concludes that targeted ultrasound could be an effective, noninvasive, drug-free way to boost insulin levels in people with type 2 diabetes. A new study asks whether ultrasound could be an effective treatment for diabetes. According to the Centers for Disease Control and Prevention (CDC), type 2 diabetes now affects more… Read More »

Looking to the Future of Neuro Devices: Exclusive Interview with Alcyone Lifesciences CEO PJ Anand

Alcyone Lifesciences is a medical technology company based out of Lowell, MA, which specializes in central nervous system (CNS) drug delivery platforms for targeted infusions of the brain or spinal cord. Their Thecaflex DRx System was recently awarded Breakthrough Device designation by the FDA, for spinal infusion of therapeutic medications. Medgadget had the opportunity to… Read More »